Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence.

MLA

Ling, Walter, et al. “Double-Blind Placebo-Controlled Evaluation of the PROMETA™ Protocol for Methamphetamine Dependence.” Addiction (Abingdon, England), vol. 107, no. 2, Feb. 2012, pp. 361–69. EBSCOhost, https://doi.org/10.1111/j.1360-0443.2011.03619.x.

APA

Ling, W., Shoptaw, S., Hillhouse, M., Bholat, M. A., Charuvastra, C., Heinzerling, K., Chim, D., Annon, J., Dowling, P. T., & Doraimani, G. (2012). Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence. Addiction (Abingdon, England), 107(2), 361–369. https://doi.org/10.1111/j.1360-0443.2011.03619.x

Chicago

Ling, Walter, Steven Shoptaw, Maureen Hillhouse, Michelle A Bholat, Charles Charuvastra, Keith Heinzerling, David Chim, Jeffrey Annon, Patrick T Dowling, and Geetha Doraimani. 2012. “Double-Blind Placebo-Controlled Evaluation of the PROMETA™ Protocol for Methamphetamine Dependence.” Addiction (Abingdon, England) 107 (2): 361–69. doi:10.1111/j.1360-0443.2011.03619.x.